The association between insulin resistance and proliferative retinopathy in type 1 diabetes

1. SJOLIE AK, STEPHENSON J, ALDINGTON S, KOHNER E, JANKA H, STEVENS L, et al., THE EURODIAB IDDM COMPLICATIONS STUDY GROUP. Retinopathy and vision loss in insulin-dependent diabetes in Europe. Ophthalmology 1997; 104:252–260.10.1016/S0161-6420(97)30327-3Search in Google Scholar

2. KLEIN R, KLEIN BE, MOSS SE, DAVIS MD, DEMETS DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102:520-526.10.1001/archopht.1984.01040030398010Search in Google Scholar

3. ROSSING K, JACOBSEN P, ROSSING P, LAURITZEN E, LUND-ANDERSEN H, PARVING HH. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 1998; 21:2007-2015.10.2337/diacare.21.11.2007Search in Google Scholar

4. MOORE DJ, GREGORY JM, KUMAH-CRYSTAL YA, SIMMONS JH. Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag 2009; 5:1015-31.Search in Google Scholar

5. AIELLO LP, DCCT/EDIC RESEARCH GROUP. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014; 37(1):17-23.10.2337/dc13-2251Search in Google Scholar

6. 6.THE DIABETES CONTROLAND COMPLICATIONS TRIALRESEARCH GROUP. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14):977-86.10.1056/NEJM199309303291401Search in Google Scholar

7. THE DIABETES CONTROL AND COMPLICATIONS TRIAL/EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS RESEARCH GROUP. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342:381-389.10.1056/NEJM200002103420603Search in Google Scholar

8. TICIANADA COSTA RODRIGUES, MIRIAM PECIS, MIRELA JOBIMDE AZEVEDO, JORGE FREITAS ESTEVES, JORGE LUIZ GROSS. Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: A 6-year follow-up study. Diabetes Res Clin Pract 2006; 74:135-40.10.1016/j.diabres.2006.03.016Search in Google Scholar

9. HADJADJ S, DULY-BOUHANICK B, BEKHERRAZ A, BRLDOUX F, GALLOIS Y, MAUCO G, et al. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 2004; 30(1):43-51.10.1016/S1262-3636(07)70088-5Search in Google Scholar

10. CHATURVEDI N, SJOELIE AK, PORTA M, ALDINGTON SJ, FULLER JH, SONGINI M, et al., EURODIAB PROSPECTIVE COMPLICATIONS STUDY. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001; 24(2):284-9.10.2337/diacare.24.2.28411213880Search in Google Scholar

11. ORCHARD TJ, CHANG YF, FERRELL RE, PETRO N, ELLIS DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 62(3):963-70.10.1046/j.1523-1755.2002.00507.x12164879Search in Google Scholar

12. ORCHARD TJ, OLSON JC, ERBEY JR, WILLIAMS K, FORREST KY, SMITHLINE KINDER L, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003; 26(5):1374-9.10.2337/diacare.26.5.137412716791Search in Google Scholar

13. OLSON JC, ERBEY JR, FORREST KY, WILLIAMS K, BECKER DJ, ORCHARD TJ. Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. Metabolism 2002; 51(2):248-54.10.1053/meta.2002.3002111833057Search in Google Scholar

14. KILPATRICK ES, RIGBY AS, ATKIN SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care 2007; 30(3):707-12.10.2337/dc06-198217327345Search in Google Scholar

15. THORN LM, FORSBLOM C, FAGERUDD J, THOMAS MC, PETTERSSON-FERNHOLM K, SARAHEIMO M, et al, FINN DIANESTUDY GROUP. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 28(8):2019-24.10.2337/diacare.28.8.201916043748Search in Google Scholar

16. WILLIAMS KV, ERBEY JR, BECKER D, ARSLANIAN S, ORCHARD TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000; 49(4):626-32.Search in Google Scholar

17. DUTA I, RUSU E, COSTACHE A, RADULIAN G, ION DA. The association between insulin resistance and advanced renal disease in Type 1 diabetes. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2015; 22(2): 167-173.10.1515/rjdnmd-2015-0021Search in Google Scholar

18. PARVANOVA A, ILIEV I, FILIPPONI M, DIMITROV BD, VEDOVATO M, TIENGO A, et al. Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 4371-4376.10.1210/jc.2003-03207615356034Search in Google Scholar

19. ANAN F, TAKAYUKI M, TAKAHASHI N, NAKAGAWA M, ESHIMA N, SAIKAWA T, et al. Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Hypertens Res 2009; 32: 299-305.10.1038/hr.2009.819262488Search in Google Scholar

20. STEPHANIE A. AMIEL, ROBERT S. SHERRWIN, DONALD C. SIMONSON, ALBERT A. LAURITANO, WILLIAM V. TAMBORLANE. Impaired Insulin Action in Puberty. N Engl J Med 1986; 315:215-219.10.1056/NEJM1986072431504023523245Search in Google Scholar

21. HIETALA K, HARJUTSALO V, FORSBLOM C, SUMMANEN P, GROOP PH, FINN DIANE STUDY GROUP. Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes. Diabetes Care 2010; 33(6):1315-9.10.2337/dc09-2278287544620185730Search in Google Scholar

22. GRAUR M, HANCU N, POPA AR. Retinopatia diabetica. In: Complicatiile cronice ale diabetului zaharat. Farma Media, Tg. Mures, 2008: 126.Search in Google Scholar

23. JILL NORRIS KOSTRABA, JANICE S DORMAN, TREVOR J ORCHARD, DOROTHY J BECKER, YUKASHI OHKI, DEMETRIUS ELLIS, et al. Contribution of Diabetes Duration Before Puberty to Development of Microvascular Complications in IDDM Subjects. Diabetes Care 1989; 12:10 686-693.10.2337/diacare.12.10.6862612303Search in Google Scholar

24. POP A, CLENCIU D, ANGHEL M, RADU S, SOCEA B, MOTA E, et al., ROMDIANESTUDY GROUP. Insulin resistance is associated with all chronic complications in type 1 diabetes. J Diabetes 2015; doi:10.1111/1753-0407.12283.10.1111/1753-0407.1228325753338Search in Google Scholar

25. KLEIN R, ZINMAN B, GARDINER R, SUISSA S, DONNELLY SM, SINAIKO AR, et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic. Diabetes 2005; 54:527-533.10.2337/diabetes.54.2.52715677511Search in Google Scholar

26. HIETALA K, FORSBLOM C, SUMMANEN P, GROOP PH. Heritability of proliferative diabetic retinopathy. Diabetes 2008; 57:2176-2180.10.2337/db07-1495249468018443200Search in Google Scholar

27. LEE YJ, CHO S, KIM SR. The association between serum adiponectin levels and nutritional status of hemodialysis patients. Ren Fail 2011; 33(5):506-11.10.3109/0886022X.2011.57679421574896Search in Google Scholar

28. QI Y, TAKAHASHI N, HILEMAN SM, PATEL HR, BERG AH, PAJVANI UB, et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10(5):524-9.10.1038/nm102915077108Search in Google Scholar

29. PANDURU NM, SARAHEIMO M, FORSBLOM C, THORN LM, GORDIN D, WADEN J, et al., ON BEHALF OF THE FINNDIANE STUDY GROUP.Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients With Type 1 Diabetes and Diabetic Nephropathy. Diabetes Care 2015.10.2337/dc14-227625720601Search in Google Scholar